Press Releases - 2023-10-11

Date	Title	Company
11-Oct-2023	Almirall's Ilumetri® (tildrakizumab) significantly improves wellbeing for patients1 and their relatives2 in moderate-to-severe plaque psoriasis	Almirall S.A.
11-Oct-2023	Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark	Mainz BioMed N.V.
11-Oct-2023	AM-Pharma Announces Positive Clinical Data From Phase 1b Study Evaluating Ilofotase Alfa in Hypophosphatasia Patients	Businesswire
11-Oct-2023	The PolG Foundation Awards Over $3.5M in Academic Grants to Pioneer POLG Research	B3C newswire
11-Oct-2023	Oxford BioTherapeutics Relocates UK Headquarters to Strategic and Cutting-Edge R&D Location at The Oxford Science Park to Accelerate Development of its Immuno-Oncology and ADC-Based Cancer Therapies	Oxford BioTherapeutics
11-Oct-2023	ANALYSIS LINKS INFLAMMATORY BIOMARKER TO NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD), REINFORCES EFFICACY OF UPLIZNA® (INEBILIZUMAB) IN REDUCING DISEASE-RELATED ATTACKS	Amgen
11-Oct-2023	Biocomposites announces new territories approved to promote STIMULAN as an antibiotic carrier in bone and soft tissue	Biocomposites
11-Oct-2023	Cytovation Reports Promising Interim Results from Phase 1/2a CICILIA Study with CyPep-1 in Solid Tumors	Cytovation ASA
11-Oct-2023	In-vivo Imaging Market is expected to reach USD 1459.71 million by 2030	The Wire Times
11-Oct-2023	Alosetron Market Industry Share, Size, Growth, Demands, Revenue, Top Leaders and Application	The Wire Times
11-Oct-2023	LECTIS (CARBOHYDRATE BINDING PROTEINS) Market By Emerging Trends, Business Strategies, Developing Technologies, Revenue and Competitive Landscape	The Wire Times
11-Oct-2023	Chronic Kidney Disease (CKD) Market would rocket up to USD 18,800.17 million by 2030	The Wire Times
11-Oct-2023	MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus	MinervaX
11-Oct-2023	The hidden scars: Stigmatisation a major impact of skin diseases across Europe	European Dermatology-Venereology Society
11-Oct-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
11-Oct-2023	OMass Therapeutics Announces its Attendance at Upcoming Conferences and Events	OMass Therapeutics
11-Oct-2023	Bristol Myers Squibb Presents New Zeposia (ozanimod) Data on Long-Term Disease Progression and Cognition in Patients with Relapsing Forms of Multiple Sclerosis	Bristol Myers Squibb
11-Oct-2023	Roche’s OCREVUS twice-yearly, 10-minute subcutaneous injection was non-inferior to intravenous infusion and provided near-complete suppression of brain lesions	Roche
11-Oct-2023	Bristol Myers Squibb Presents New Zeposia (ozanimod) Data on Long-Term Disease Progression and Cognition in Patients with Relapsing Forms of Multiple Sclerosis	Businesswire
11-Oct-2023	Roche’s Vabysmo maintained vision improvements with extended treatment intervals up to four months for people with retinal vein occlusion (RVO) in phase III studies	Roche